Why the study?
Do the PESI and 2019 ESC risk stratification scores accurately predict 30-day mortality in a Southeast Asian population with acute pulmonary embolism?
Do the PESI and 2019 ESC risk stratification scores accurately predict 30-day mortality in a Southeast Asian population with acute pulmonary embolism?
The PESI and 2019 ESC risk stratification scores are valid tools for predicting 30-day mortality in Southeast Asian patients with acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Supports PESI/ESC stratification in Southeast Asian APE patients; extends validation data but leaves open broader adoption.
Our study represents a good validation of the PESI and 2019 ESC risk stratification to predict 30-day mortality after APE diagnosis in the Southeast Asian population.
No takes yet. Share an insight, caveat, or question.
Bumroongkit et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: